
XBiotech Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
XBiotech is a clinical-stage biopharmaceutical company based in Austin, Texas, that discovers and develops therapeutic antibodies targeting inflammatory and oncological diseases. Its research focuses on identifying antibodies from the immune systems of healthy individuals for development into treatments.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| SIMARD JOHNDirector | Buy | $711K | 368,524at $1.93 | Oct 26, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable XBIT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.